Skip to main content
OpenTrials
Completed

NCT Number: NCT07651423

Evaluating the Effect of Blue m Gel on Healing of Palatal Donor Site Versus Using Diode Laser

A sample size of 40 patients, Group A of 20 patients treated with blue m gel and Group B of 20 patient treated with diode laser were included in this study after free gingival grafts harvested from the hard palate. Participants were assessed for the amount and duration of bleeding, pain duration, and the risk of infection 2, 7,14, 30 days post-operative

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Delta University For Science and Technology

Gamasa, Dakhalia, 35516, Egypt

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • healthy

Exclusion criteria

  • smokers

Treatment and study plan

Blueb m gel

Procedure

application of blue m oxygen releasing oral gel to the palate after free gingival graft

laser therapy

Procedure

Application of Low level laser therapy to the Paltal donor site after free gingival graft harvesting

Primary outcomes

  1. pain intensity

    Time frame: one month

    visual analogue scale

Secondary outcomes

  1. Bleeding time

    Time frame: One week

    Presence or absence of bleeding

Sponsors and collaborators

Lead sponsor

Delta University for Science and Technology

Other

Registry information

Important dates

Study start
2025
Primary completion
2025
Study completion
2026
First posted
Jun 16, 2026
Registry last updated
Jun 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.